Literature DB >> 17496224

Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model.

Christopher Cawthorne1, Ric Swindell, Ian J Stratford, Caroline Dive, Arkadiusz Welman.   

Abstract

Doxycycline (Dox) controlled Tet systems provide a powerful and commonly used method for functional studies on the consequences of gene overexpression/downregulation. However, whereas Dox delivery in tissue culture in vitro is relatively simple, the situation in vivo is more complex. Several methods of Dox delivery in vivo have been described-e.g., in drinking water containing alcohol, in drinking water containing various concentrations of sucrose, and in feed. Unfortunately there are no reports directly comparing the advantages and disadvantages of these diverse methods, and there is no generally accepted standard. We therefore compared four non-invasive methods of Dox delivery in vivo-in drinking water, by gavage, as a jelly, and in standard feed. To assess the delivery of Dox by these methods, we used a subcutaneous xenograft model based on colorectal carcinoma cells engineered for Dox-inducible expression of an activated mutant of c-Src and the luciferase reporter gene. Our results indicate that feed represents the most favorable method of Dox administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496224      PMCID: PMC2062538     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  15 in total

1.  Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.

Authors:  J Dai; R Shen; M Sumitomo; J S Goldberg; Y Geng; D Navarro; S Xu; J A Koutcher; M Garzotto; C T Powell; D M Nanus
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  The cytotoxic activity of the bacteriophage lambda-holin protein reduces tumour growth rates in mammary cancer cell xenograft models.

Authors:  Chukwuma A Agu; Reinhard Klein; Sonja Schwab; Marielle König-Schuster; Petra Kodajova; Michael Ausserlechner; Bernhard Binishofer; Udo Bläsi; Brian Salmons; Walter H Günzburg; Christine Hohenadl
Journal:  J Gene Med       Date:  2006-02       Impact factor: 4.565

3.  Microencapsulated iNOS-expressing cells cause tumor suppression in mice.

Authors:  Weiming Xu; Lizhi Liu; Ian G Charles
Journal:  FASEB J       Date:  2001-12-28       Impact factor: 5.191

4.  Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth.

Authors:  Kwang S Suh; Michihiro Mutoh; Michael Gerdes; John M Crutchley; Tomoko Mutoh; Lindsay E Edwards; Rebecca A Dumont; Pooja Sodha; Christina Cheng; Adam Glick; Stuart H Yuspa
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

5.  Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.

Authors:  Leiming Li; Xiaoyu Lin; Michael Staver; Alexander Shoemaker; Dimitri Semizarov; Stephen W Fesik; Yu Shen
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

6.  Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo.

Authors:  Addolorata Maria Luce Coluccia; Silvia Perego; Loredana Cleris; Rosalind Helen Gunby; Lorena Passoni; Edoardo Marchesi; Franca Formelli; Carlo Gambacorti-Passerini
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

Review 7.  Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes.

Authors:  Christian Berens; Wolfgang Hillen
Journal:  Eur J Biochem       Date:  2003-08

8.  CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.

Authors:  Jürgen Eberle; Lothar F Fecker; Amir M Hossini; Thomas Wieder; Peter T Daniel; Constantin E Orfanos; Christoph C Geilen
Journal:  Oncogene       Date:  2003-12-11       Impact factor: 9.867

9.  Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil.

Authors:  Shulin Wang; Wafik S El-Deiry
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

10.  Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expression.

Authors:  Arkadiusz Welman; Christopher Cawthorne; Jane Barraclough; Nigel Smith; Gareth J Griffiths; Rachel L Cowen; Judith C Williams; Ian J Stratford; Caroline Dive
Journal:  J Cell Biochem       Date:  2005-04-15       Impact factor: 4.429

View more
  39 in total

1.  Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin.

Authors:  Zetang Wu; Marina Mata; David J Fink
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  MicroRNA-mediated disruption of dendritogenesis during a critical period of development influences cognitive capacity later in life.

Authors:  Quan Lin; Ravikumar Ponnusamy; Jocelyn Widagdo; Jung A Choi; Weihong Ge; Christine Probst; Tyler Buckley; Mimi Lou; Timothy W Bredy; Michael S Fanselow; Keqiang Ye; Yi E Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-08       Impact factor: 11.205

3.  A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse.

Authors:  Jenny D Y Chow; John T Price; Margaret M Bills; Evan R Simpson; Wah Chin Boon
Journal:  Transgenic Res       Date:  2011-05-26       Impact factor: 2.788

4.  Targeting RLIP with CRISPR/Cas9 controls tumor growth.

Authors:  Jyotsana Singhal; Shireen Chikara; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

5.  PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.

Authors:  Hyungsoo Kim; Heejung Kim; Yongmei Feng; Yan Li; Hironari Tamiya; Stefania Tocci; Ze'ev A Ronai
Journal:  Sci Transl Med       Date:  2020-07-08       Impact factor: 17.956

6.  Intraspinal transplantation of neurogenin-expressing stem cells generates spinal cord neural progenitors.

Authors:  J Simon Lunn; Crystal Pacut; Emily Stern; Stacey A Sakowski; J Matthew Velkey; Sue O'Shea; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2012-01-08       Impact factor: 5.996

7.  Metformin Promotes 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake in Hepatocellular Carcinoma Cells Through FoxO1-Mediated Downregulation of Glucose-6-Phosphatase.

Authors:  Zhengjie Wang; Fei Kang; Yongheng Gao; Yi Liu; Xiaolong Xu; Xiaowei Ma; Wenhui Ma; Weidong Yang; Jing Wang
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

8.  RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.

Authors:  Haiying Cheng; Yiyu Zou; Jeffrey S Ross; Kai Wang; Xuewen Liu; Balazs Halmos; Siraj M Ali; Huijie Liu; Amit Verma; Cristina Montagna; Abraham Chachoua; Sanjay Goel; Edward L Schwartz; Changcheng Zhu; Jidong Shan; Yiting Yu; Kira Gritsman; Roman Yelensky; Doron Lipson; Geoff Otto; Matthew Hawryluk; Philip J Stephens; Vincent A Miller; Bilal Piperdi; Roman Perez-Soler
Journal:  Cancer Discov       Date:  2015-09-14       Impact factor: 39.397

9.  Protective effect of doxycycline on germinal epithelial loss caused by a high-fat diet.

Authors:  Ivan Delgado-Enciso; Alejandro García-Rivera; M Violeta M Madrigal-Pérez; Alejandrina Rodriguez-Hernandez; Agustin Lugo-Radillo; Hector R Galvan-Salazar; Alejandro D Soriano-Hernández; Fernando Gómez-Tapia; Rafael Martinez-Martinez; Laura L Valdez-Velazquez; Oscar A Newton-Sanchez; Rafael Gonzalez-Alvarez; Iram P Rodriguez-Sanchez; Valery Melnikov; Agustin Lara-Esqueda; Jose Guzman-Esquivel
Journal:  Int Urol Nephrol       Date:  2013-11-28       Impact factor: 2.370

10.  Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.

Authors:  Jane Barraclough; Cassandra Hodgkinson; Alison Hogg; Caroline Dive; Arkadiusz Welman
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.